CRIMSON project team and outputs

The CRIMSON project team thanks all the patients and health professionals who took part in this project to talk about their experiences of making treatment decisions about RRMS.

The Considering Risk and Benefits in Multiple Sclerosis Treatment Selection (CRIMSON) applicants were Manzano A, Ford HL, Pepper G, Chataway J, Schmierer K, Meads D, Bekker HL, Pavitt S. The MS Society funded the project (2016-2019) [IRAS 199646)]. For more details see crimson.leeds.ac.uk

The project was reviewed by MS doctors, health researchers and social scientists, and women and men with MS from Leeds and London (UK). Dr Ieva Eskyte and Dr Ed Webb were the project research fellows. Dr Yasmina Okan, Dr Joachim Marti, Ms Victoria Pattinson and Dr Barbara Potrata contributed to the project outputs.

The research is supported by the National Institute for Health Research (NIHR) infrastructure at Leeds. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care, or the MS Society.

The booklet and web design were carried out by Magpie.

Manzano A, Ford HL, Potrata B, Eskyte I, Meads D, Webb E, Pepper, G, Schmierer K, Chataway J, Pavitt S, Bekker HL. Treatment Decision Making and Relapsing Remitting Multiple Sclerosis. The CRIMSON Project Decision Aid Booklet. (July, 2019). University of Leeds. Leeds

Manzano A, Ford HL, Meads D, Webb E, Pepper, G, Eskyte I, Potrata B, Schmierer K, Chataway J, Pavitt S, Bekker HL. Treatment Decision Making and Relapsing Remitting Multiple Sclerosis. The CRIMSON Project Decision Aid Website. (Oct, 2019). University of Leeds. Leeds (https://www.relapsingmsdecisions.com)